Zein Mersini Besharat

Pubblicazioni

Titolo Pubblicato in Anno
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients CURRENT ONCOLOGY REPORTS 2024
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers? PHARMACOLOGY & THERAPEUTICS 2024
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling NPJ PRECISION ONCOLOGY 2024
Notch3-regulated microRNAs impair CXCR4- CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL ONCOGENE 2024
Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL ONCOGENE 2024
Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Building an in vitro model of sarcopenic obesity INTERNATIONAL JOURNAL OF BONE FRAGILITY 2024
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food NUTRIENTS 2023
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy CANCERS 2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer EUROPEAN UROLOGY ONCOLOGY 2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance BIOMÉDECINE & PHARMACOTHÉRAPIE 2023
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion BIOMEDICINES 2023
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors NEOPLASIA 2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study SCIENTIFIC REPORTS 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value BIOMARKER RESEARCH 2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer ENDOCRINE 2023
Environmental contaminants acting as endocrine disruptors modulate atherogenic processes: New risk factors for cardiovascular diseases in women? BIOMOLECULES 2022
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders THERANOSTICS 2022
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside TRANSLATIONAL RESEARCH 2022

ERC

  • LS2_10
  • LS3_8
  • LS3_12
  • LS4_5
  • LS4_6

KET

  • Big data & computing
  • Life-science technologies & biotechnologies

Interessi di ricerca

Precision Medicine; Network medicine; Bioinformatics; Omics; Data integration; Cancer; Metabolic disorders; Obesity; Biomarkers; Circulating microRNAs; ncRNAs; Signalling pathways; Molecular Mechanisms; Stem cells; Cancer stem cells. 

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma